Lazard Asset Management
XTNT icon

Lazard Asset Management’s Xtant Medical Holdings XTNT Stock Holding History

Lazard Asset Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Sell
19,562
-3,158
-14% -$1.94K ﹤0.01% 1823
2025
Q4 		$17.8K Buy
+22,720
New +$16.5K ﹤0.01% 1832

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lazard Asset Management's XTNT Position: Q1 2026 in Review

Lazard Asset Management reduced its Xtant Medical Holdings (XTNT) stake by 14% in Q1 2026, selling an estimated $1.94K and leaving 19,562 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Lazard Asset Management first reported a position in XTNT in Q4 2025 and has held it in 2 quarters since. The position peaked at $17.8K in Q4 2025. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Lazard Asset Management held 19,562 shares of Xtant Medical Holdings worth $10.9K as of Q1 2026.
  • Lazard Asset Management sold 3,158 Xtant Medical Holdings shares in Q1 2026, an estimated $1.94K.
  • Xtant Medical Holdings made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1823 holding.
  • Lazard Asset Management first reported a position in Xtant Medical Holdings in Q4 2025 and has held it in 2 quarters since.
  • Lazard Asset Management's Xtant Medical Holdings position peaked at $17.8K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.